A multicentre, phase III, double-blind, randomised clinical trial to assess the efficacy and safety of LPRI-CF113 in the treatment of Endometriosis versus placebo after 3 medication cycles followed by 3 open-label medication cycles
Chemo Research S. L.
The study is aiming to test whether LPRI-CF113 can help in Endometriosis patients within 6 cycles
East of England - Cambridge South Research Ethics Committee
Date of REC Opinion
12 Oct 2022
Further Information Favourable Opinion